期刊
BREAST CANCER RESEARCH AND TREATMENT
卷 120, 期 3, 页码 547-555出版社
SPRINGER
DOI: 10.1007/s10549-009-0408-z
关键词
Nanoshells; Reflectance confocal microscopy; Breast cancer; Molecular imaging; Tumor margins; Intraoperative detection
类别
资金
- Department of Defense Congressionally Directed Breast Cancer Research Program Era of Hope Scholar Award
- Center for Biological and Environmental Nanotechnology [EEC-0118007, EEC-0647452]
- John and Ann Doerr Fund for Computational Biomedicine
Obtaining negative margins is critical for breast cancer patients undergoing conservation therapy in order to reduce the reemergence of the original cancer. Currently, breast cancer tumor margins are examined in a pathology lab either while the patient is anesthetized or after the surgical procedure has been terminated. These current methods often result in cancer cells present at the surgical resection margin due to inadequate margin assessment at the point of care. Due to such limitations evident in current diagnoses, tools for increasing the accuracy and speed of tumor margin detection directly in the operating room are still needed. We are exploring the potential of using a nano-biophotonics system to facilitate intraoperative tumor margin assessment ex vivo at the cellular level. By combining bioconjugated silica-based gold nanoshells, which scatter light in the near-infrared, with a portable FDA-approved reflectance confocal microscope, we first validate the use of gold nanoshells as effective reflectance-based imaging probes by evaluating the contrast enhancement of three different HER2-overexpressing cell lines. Additionally, we demonstrate the ability to detect HER2-overexpressing cells in human tissue sections within 5 min of incubation time. This work supports the use of targeted silica-based gold nanoshells as potential real-time molecular probes for HER2-overexpression in human tissue.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据